CAH
44
7
SWK
53
4
JNPR
59
3
GE
60
5
LOW
42
14
DOV
48
2
EXPE
83
8
HD
43
8
MO
47
6
PWR
63
3
KIM
58
2
ORCL
49
3
TXN
29
4
UNH
42
6
MTB
38
4
ABBV
40
5
MET
58
2
SRE
37
9
AIZ
61
5
PNW
55
3
CAH
44
7
SWK
53
4
JNPR
59
3
GE
60
5
LOW
42
14
DOV
48
2
EXPE
83
8
HD
43
8
MO
47
6
PWR
63
3
KIM
58
2
ORCL
49
3
TXN
29
4
UNH
42
6
MTB
38
4
ABBV
40
5
MET
58
2
SRE
37
9
AIZ
61
5
PNW
55
3
Financhill
Back

Windtree Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
17

WINT
Windtree Therapeutics

Last Price:
$0.33
Seasonality Move:
-9.01%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
17
Windtree Therapeutics (WINT) is a Sell

Is Windtree Therapeutics a Buy, Sell or Hold?

  • The current Windtree Therapeutics [WINT] share price is $0.34. The Score for WINT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • WINT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WINT Stock Price Chart

What is Windtree Therapeutics's stock price today?

  • The Windtree Therapeutics share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

WINT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 30.42 Sell
Chaikin Money Flow: 297647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.36 - 0.52) Sell
Bollinger Bands (100): (-0.61 - 7.41) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.71 - 15.03) Sell

WINT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Sell
20-day SMA: 0.43 Sell
50-day SMA: 0.59 Sell
200-day SMA: 4.12 Sell
8-day EMA: 0.36 Sell
20-day EMA: 0.43 Sell
50-day EMA: 1.01 Sell
200-day EMA: 8.89 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.97 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.02 Sell

Windtree Therapeutics Earnings Growth & WINT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $89.20 per share, and an increase next year of $2.80 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Windtree Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):